AU7112374A - 1,3-oxygenated &-oestratrienes - Google Patents

1,3-oxygenated &-oestratrienes

Info

Publication number
AU7112374A
AU7112374A AU71123/74A AU7112374A AU7112374A AU 7112374 A AU7112374 A AU 7112374A AU 71123/74 A AU71123/74 A AU 71123/74A AU 7112374 A AU7112374 A AU 7112374A AU 7112374 A AU7112374 A AU 7112374A
Authority
AU
Australia
Prior art keywords
oestratrienes
oxygenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU71123/74A
Other versions
AU477010B2 (en
Inventor
Dr. Henry Laurent Dr. Helmut Hofmeister Prof. Dr. Rudolf Wiechert Dr. Friedgood Neumann Dr. Morishige Nishino Dr. Klaus Prezewowsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/en
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/en
Application filed by Schering AG filed Critical Schering AG
Publication of AU7112374A publication Critical patent/AU7112374A/en
Application granted granted Critical
Publication of AU477010B2 publication Critical patent/AU477010B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
AU71123/74A 1973-07-13 1974-07-11 1,3-oxygenated &-oestratrienes Expired AU477010B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (en) 1973-07-13 1973-07-13 1.3-oxygenated 8-alpha-estratrienes, processes for their production and pharmaceuticals containing them
DEDE82336 1973-07-13
DEDE824267 1974-05-31
DE19742426777 DE2426777A1 (en) 1974-05-31 1974-05-31 1,3-Oxygenated-8-alpha-oestratrienes for post-menopausal disorders - with vaginotropic, but low uterotrophic activity

Publications (2)

Publication Number Publication Date
AU7112374A true AU7112374A (en) 1976-01-15
AU477010B2 AU477010B2 (en) 1976-10-14

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71123/74A Expired AU477010B2 (en) 1973-07-13 1974-07-11 1,3-oxygenated &-oestratrienes

Country Status (18)

Country Link
JP (1) JPS5821639B2 (en)
AT (1) ATA575574A (en)
AU (1) AU477010B2 (en)
CA (1) CA1030951A (en)
CH (2) CH609064A5 (en)
CS (2) CS182300B2 (en)
DD (1) DD114066A5 (en)
DK (1) DK133051C (en)
ES (1) ES428226A1 (en)
FI (1) FI54131C (en)
FR (1) FR2236505B1 (en)
GB (1) GB1479934A (en)
HU (1) HU169791B (en)
IE (1) IE39872B1 (en)
IL (1) IL45259A (en)
NO (1) NO742546L (en)
SE (1) SE7409151L (en)
SU (1) SU626705A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611426B2 (en) * 1987-03-31 1991-06-13 Schering Aktiengesellschaft 17alpha-ethinyl-17beta-hydroxy-18-methyl-4, 15-estradien-3-one and new intermediate products for this process

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (en) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Process for the preparation of 1,3-oxygenated 8α-estatrienes
JPS5862734U (en) * 1981-10-22 1983-04-27 日工株式会社 formwork support sabot
JPS59146759A (en) * 1984-01-06 1984-08-22 株式会社日立製作所 Automatic screwing device
JPS60155376A (en) * 1984-01-24 1985-08-15 松下電器産業株式会社 Nut float detection apparatus
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (en) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович 3-o-sulfamoiloxy-6-oxa-7β-methyl-d-homo-8α-estra-1,3,5(10)-trien-17α-one application for the breast cancer treatment, including the triple negative form, and its production method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611426B2 (en) * 1987-03-31 1991-06-13 Schering Aktiengesellschaft 17alpha-ethinyl-17beta-hydroxy-18-methyl-4, 15-estradien-3-one and new intermediate products for this process

Also Published As

Publication number Publication date
IE39872L (en) 1975-01-13
FI54131C (en) 1978-10-10
IL45259A (en) 1977-10-31
ES428226A1 (en) 1976-07-16
CS182300B2 (en) 1978-04-28
FI213974A (en) 1975-01-14
CH609064A5 (en) 1979-02-15
FI54131B (en) 1978-06-30
SE7409151L (en) 1975-01-14
CH614217A5 (en) 1979-11-15
IE39872B1 (en) 1979-01-17
DK368074A (en) 1975-03-17
DK133051C (en) 1976-08-16
CS182260B2 (en) 1978-04-28
AU477010B2 (en) 1976-10-14
DK133051B (en) 1976-03-15
IL45259A0 (en) 1974-10-22
DD114066A5 (en) 1975-07-12
HU169791B (en) 1977-01-28
ATA575574A (en) 1978-05-15
CA1030951A (en) 1978-05-09
JPS5821639B2 (en) 1983-05-02
FR2236505B1 (en) 1977-07-08
GB1479934A (en) 1977-07-13
FR2236505A1 (en) 1975-02-07
SU626705A3 (en) 1978-09-30
NO742546L (en) 1975-02-10
JPS5032160A (en) 1975-03-28

Similar Documents

Publication Publication Date Title
IL46162A (en) 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1- )-isoquinolines
CA1008860A (en) 1-phenyl-substituted 1,3,5-triazines
CA1023746A (en) 2,6-dimethyl-4-phenyl-1,4-dihydropyridines
MY8100330A (en) 1,3-diketo-1,2,3,4-tetrahydrosoquinolines
AU477010B2 (en) 1,3-oxygenated &-oestratrienes
CA1030950A (en) 1,3-OXYGENATED 8.alpha.-OESTRATRIENES
ZA744478B (en) 1,3-oxygenated 8alpha-oestratrienes
CA1026760A (en) 3,4-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
AU7278974A (en) 2,3-dihydrobenzofuranyl-7-n-methylcarbamates
AU6558474A (en) 7-alkyl-delta 3,5-steroids
CA1008072A (en) Amino substituted 1,2,4-triazinones
CA1029726A (en) 1,8-naphthyridine-3-carboxamidetetrazolyl derivatives
CA1024140A (en) 6-anilino-1,4,5-trihydroxyanthraquinones
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
AU7271274A (en) 1,2-oxaphospholanes
AU6776774A (en) 2,3-dhydro-benzofurans
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
AU6593074A (en) 1, 4-dihydro-2-h-isoquinoline
CA1021331A (en) 9,12-bridged ethenoanthracenes and compounds derived therefrom
CA1031779A (en) 1,3,4-thiadiazol-2-yl-ureas with selective-herbicidal action
CA1032163A (en) 1,2-dihydrophthalazine-1-acetic acids
AU478074B2 (en) 1,3-oxygenated s-oestratrienes
AU489033B2 (en) HERDICIDAL l, 3, 4-THIADIAZOL-2-YL-UREAS
CA992960A (en) 2,2'-anhydro-b-d-arabinofuranosyl-5-fluorocytosine
AU7206674A (en) 2, 2-disubstitute-benzodioxoles